SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 254 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,716,468 | -7.2% | 352,429 | +1.2% | 0.92% | -1.9% |
| Q2 2023 | $10,468,094 | -18.3% | 348,240 | -1.5% | 0.94% | -21.0% |
| Q1 2023 | $12,813,500 | +104868.5% | 353,671 | +3.3% | 1.19% | -2.3% |
| Q4 2022 | $12,207 | -99.9% | 342,226 | -3.6% | 1.22% | -3.5% |
| Q3 2022 | $12,018,000 | +15.3% | 355,024 | -1.5% | 1.26% | +21.7% |
| Q2 2022 | $10,425,000 | -4.2% | 360,483 | +7.0% | 1.04% | +20.3% |
| Q1 2022 | $10,887,000 | +16.4% | 336,846 | +5.0% | 0.86% | +21.8% |
| Q4 2021 | $9,353,000 | +3.0% | 320,742 | -5.8% | 0.71% | +0.6% |
| Q3 2021 | $9,084,000 | -2.0% | 340,617 | +13.1% | 0.70% | -0.1% |
| Q2 2021 | $9,272,000 | +12.3% | 301,139 | -4.5% | 0.70% | +9.0% |
| Q1 2021 | $8,253,000 | – | 315,241 | – | 0.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |